Niche-Selective Inhibition of Pathogenic Th17 Cells by Targeting Metabolic Redundancy.
Wu L, Hollinshead KER, Hao Y, Au C, Kroehling L, Ng C, Lin WY, Li D, Silva HM, Shin J, Lafaille JJ, Possemato R, Pacold ME, Papagiannakopoulos T, Kimmelman AC, Satija R, Littman DR.
Cell. 2020 Aug 6;182(3):641-654.e20. doi: 10.1016/j.cell.2020.06.014. Epub 2020 Jul 1.
PMID:32615085
Glucose-6-phosphate isomerase deficiency.
Kugler W, Lakomek M.
Baillieres Best Pract Res Clin Haematol. 2000 Mar;13(1):89-101. doi: 10.1053/beha.1999.0059.
PMID:10916680
RHBDF1 deficiency suppresses melanoma glycolysis and enhances efficacy of immunotherapy by facilitating glucose-6-phosphate isomerase degradation via TRIM32.
Wang L, Song YY, Wang Y, Liu XX, Yin YL, Gao S, Zhang F, Li LY, Zhang ZS.
Pharmacol Res. 2023 Dec;198:106995. doi: 10.1016/j.phrs.2023.106995. Epub 2023 Nov 17.